Allspring Global Investments
AMRX icon

Allspring Global Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Allspring Global Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.9M Buy
3,295,533
+745,961
+29% +$10.2M 0.09% 263
2026
Q1 		$32.4M Buy
2,549,572
+1,069,400
+72% +$14.4M 0.05% 402
2025
Q4 		$18.7M Buy
1,480,172
+344,373
+30% +$3.94M 0.03% 558
2025
Q3 		$11.8M Buy
1,135,799
+1,062,045
+1,440% +$9.53M 0.02% 664
2025
Q2 		$606K Buy
73,754
+13,187
+22% +$99.4K ﹤0.01% 1288
2025
Q1 		$508K Buy
60,567
+21,079
+53% +$176K ﹤0.01% 1452
2024
Q4 		$313K Buy
39,488
+689
+2% +$5.78K ﹤0.01% 1569
2024
Q3 		$323K Sell
38,799
-17,152
-31% -$134K ﹤0.01% 1579
2024
Q2 		$355K Sell
55,951
-73,201
-57% -$465K ﹤0.01% 1584
2024
Q1 		$783K Sell
129,152
-8,612
-6% -$48.6K ﹤0.01% 1426
2023
Q4 		$836K Sell
137,764
-146,925
-52% -$654K ﹤0.01% 1380
2023
Q3 		$1.2M Sell
284,689
-340,790
-54% -$1.27M ﹤0.01% 1321
2023
Q2 		$1.94M Sell
625,479
-1,283,443
-67% -$2.73M ﹤0.01% 1246
2023
Q1 		$2.65M Buy
1,908,922
+325,553
+21% +$648K ﹤0.01% 1167
2022
Q4 		$3.15M Buy
1,583,369
+775,707
+96% +$1.74M 0.01% 1112
2022
Q3 		$1.63M Buy
807,662
+481,227
+147% +$1.35M ﹤0.01% 1297
2022
Q2 		$1.04M Buy
326,435
+1,186
+0.4% +$4.3K ﹤0.01% 1423
2022
Q1 		$1.36M Sell
325,249
-122,451
-27% -$542K ﹤0.01% 1718
2021
Q4 		$2.14M Buy
+447,700
New +$2.23M ﹤0.01% 1502

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Allspring Global Investments's AMRX Position: Q2 2026 in Review

Allspring Global Investments increased its Amneal Pharmaceuticals (AMRX) stake by 29% in Q2 2026, buying an estimated $10.2M and bringing the position to 3,295,533 shares worth $55.9M. The position accounts for 0.09% of the portfolio, ranked #263.

Allspring Global Investments first reported a position in AMRX in Q4 2021 and has held it in 19 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Allspring Global Investments held 3,295,533 shares of Amneal Pharmaceuticals worth $55.9M as of Q2 2026.
  • Allspring Global Investments bought 745,961 Amneal Pharmaceuticals shares in Q2 2026, an estimated $10.2M.
  • Amneal Pharmaceuticals made up 0.09% of Allspring Global Investments's portfolio in Q2 2026, its #263 holding.
  • Allspring Global Investments first reported a position in Amneal Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.